XML 22 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   136,952,000      
Beginning balance at Dec. 31, 2021 $ 1,106,917 $ 137 $ 1,449,305 $ (5,334) $ (337,191)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchase of common stock (in shares)   (12,709,000)      
Repurchase of common stock (323,528) $ (13) (323,515)    
Issuance of common stock upon exercise of stock options and ESPP (in shares)   437,000      
Issuance of common stock upon exercise of stock options and ESPP 6,475   6,475    
Net share settlement of equity awards (in shares)   1,794,000      
Net share settlement of equity awards (26,547) $ 2 (26,549)    
Share-based compensation expense 138,788   138,788    
Other comprehensive income (loss) (52,154)     (52,154)  
Net income (loss) 266,638       266,638
Ending balance (in shares) at Dec. 31, 2022   126,474,000      
Ending balance at Dec. 31, 2022 1,116,589 $ 126 1,244,504 (57,488) (70,553)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchase of common stock (in shares)   (26,506,000)      
Repurchase of common stock (337,709) $ (26) (337,683)    
Issuance of common stock upon exercise of stock options and ESPP (in shares)   512,000      
Issuance of common stock upon exercise of stock options and ESPP 4,163 $ 1 4,162    
Net share settlement of equity awards (in shares)   2,344,000      
Net share settlement of equity awards (16,438) $ 2 (16,440)    
Share-based compensation expense 136,787   136,787    
Net proceeds from capped call related to conversions and extinguishments of 2023 notes and 2025 notes 297   297    
Other comprehensive income (loss) 22,749     22,749  
Net income (loss) $ 18,180       18,180
Ending balance (in shares) at Dec. 31, 2023 102,823,700 102,824,000      
Ending balance at Dec. 31, 2023 $ 944,618 $ 103 1,031,627 (34,739) (52,373)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchase of common stock (in shares)   (2,116,000)      
Repurchase of common stock (18) $ (2) (16)    
Issuance of common stock upon exercise of stock options and ESPP (in shares)   859,000      
Issuance of common stock upon exercise of stock options and ESPP 2,633 $ 1 2,632    
Net share settlement of equity awards (in shares)   3,313,000      
Net share settlement of equity awards (9,236) $ 3 (9,239)    
Share-based compensation expense 89,546   89,546    
Other comprehensive income (loss) 2,506     2,506  
Net income (loss) $ (837,068)       (837,068)
Ending balance (in shares) at Dec. 31, 2024 104,880,048 104,880,000      
Ending balance at Dec. 31, 2024 $ 192,981 $ 105 $ 1,114,550 $ (32,233) $ (889,441)